T1 breast cancer: Identification of patients at low risk of axillary lymph node metastases

Breast Cancer Research and Treatment

Volumn 76, Issue 1, 2002, Pages 11-17

  Bader, Arnim A ^a,b   Tio, Joke ^a   Petru, Edgar ^b   Bühner, Michael ^a   Pfahlberg, Annette ^c   Volkholz, Hildegard ^a   Tulusan, Augustinus H ^a  

^a INSTITUTE OF PATHOLOGY   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c Department of Medical Informatics ^*  (Germany)

Author keywords

Axillary lymph node dissection; Breast cancer; Lymph node metastases; Multivariate analysis; Prediction

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HORMONE RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN P53; UROKINASE RECEPTOR;

AGGRESSIVENESS; ARTICLE; AXILLARY LYMPH NODE; BONE MARROW; BREAST CARCINOMA; CANCER INVASION; CANCER RISK; CELL CYCLE S PHASE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; METASTASIS; MULTIPLE CANCER; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONCOGENE NEU; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TISSUE SECTION; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0036838049     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020231300974     Document Type: Article

References (28)

1. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP (eds): American Joint Committee on Cancer Staging Manual. 5th edn, JB Lippincott, Philadelphia, 1997
2. Cady B: Use of primary breast carcinoma characteristics to predict lymph node metastases. Cancer 79: 1856-1861, 1997
3. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A: Tumor development, histology and grade of breast cancers: prognosis and progression. Int J Cancer 66: 413-419, 1996
4. Heimann R, Bradley J, Hellman S: The benefits of mammography are not limited to women of ages older than 50 years. Cancer 82: 2221-2226, 1998
5. Early Breast Cancer Trialists Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. One hundred thirty three randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339: 1-15, 71-85, 1992
6. Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I, Kreienberg R: Long-term morbidity following axillary dissection in breast cancer patients - clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 64: 275-286, 2000
7. Chadha M, Chabon AB, Friedmann P, Vikram B: Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer 73: 350-353, 1994
8. Ravdin PM, DeLaurentiis M, Vendely T, Clark GM: Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 86: 1771-1775, 1994
9. Barth A, Craig PH, Silverstein MJ: Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 79: 1918-1922, 1997
10. Mustafa IA, Cole B, Wanebo HJ, Bland KI, Chang HR: The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg 132: 384-391, 1997
11. Olivotto IA, Jackson JSH, Mates D, Andersen S, Davidson W, Bryce CJ, Ragaz J: Prediction of axillary lymph node involvement of women with breast carcinoma: a multivariate analysis. Cancer 83: 948-955, 1998
12. Sauer R, Tulusan A, Lang N: Can breast irradiation be omitted in low-risk breast cancer patients after segmentectomy? First results of the Erlangen protocol. Int J Radiat Oncol Biol Phys 27(suppl 1): 146, 1993 (Abstract)
13. ICD-O: International Classification of Diseases for Oncology. 2nd edn. World Health Organization, Geneva, 1990
14. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histologic grade in breast cancer: experience from a large study with long term follow up. Histopathology 19: 403-410, 1991
15. Lagios NM, Margolin FR, Westdahl PR, Rose NM: Mammographically detected carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63: 619-624, 1989
16. Silverstein MJ, Poller DN, Waisman JR: Prognostic classification of breast ductal carcinoma in situ. Lancet 345: 1154-1157, 1995
17. Rose DSC, Maddox PH, Brown DC: Which proliferation for immunohistology? A comparison of five antibodies. J Clin Pathol 47: 1010-1014, 1994
18. Stephens RW, Brunner N, Janicke F, Schmitt M: The urokinase plasminogen activator system as a target for prognostic studies in breast cancer. Breast Cancer Res Treat 52: 99-111, 1998
19. Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, Kaul S, Bastert G: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 88: 1652-1658, 1996
20. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham L, Deutsch M, Montague E, Margolese R, Foster R: Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312: 674-681, 1985
21. Harris JR, Osteen RT: Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 5: 17-21, 1985
22. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337: 949-955, 1997
23. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P: Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer 73: 664-667, 1994
24. Cady B: The need to reexamine axillary lymph node dissection in invasive breast cancer [editorial]. Cancer 73: 505-508, 1994
25. Saiz E, Toonkel R, Poppiti Jr RJ, Robinson MJ: Infiltrating breast carcinoma smaller than 0.5 centimeters: is lymph node dissection necessary? Cancer 85: 2206-2211, 1999
26. Maibenco DC, Weiss LK, Pawlish KS, Severson RK: Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer 85: 1530-1536, 1999
27. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR: Sentinel lymph node biopsy for breast cancer - not yet the standard of care. N Engl J Med 339: 990-995, 1998
28. Jacobs TW, Siziopikou KP, Prioleau JE, Raza S, Baum JK, Hayes DF: Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor? Mod Pathol 11: 259-264, 1998